Why lifecycle governance is now the real test for AI in pharmacovigilance
31 August 2026
No Comments
Jason Bryant General manager, AI platforms at ArisGlobal. ABSTRACT: Pharmacovigilance teams have largely
Tag: PHARMACOVIGILANCE
The Productivity Crisis That Persists Even Now: What Will It Take to Free Up PV Professionals to Assess Safety, Rather Than Coordinate Data?
2 July 2026
No Comments
Gyöngyi Mezey Director of Product Management, Qinecsa Solutions Abstract: Safety databases transformed individual
Applying AI to adverse event case processing: sharpening the impact of pharmacovigilance
20 June 2025
No Comments
For major pharma brands, for which pharmacovigilance (PV) has up to now primarily involved
Findings from Boehringer Ingelheim’s recent rollout of AI in Pharmacovigilance (PV)
20 June 2025
No Comments
What was the opportunity? Claudia Lehman, Boehringer Ingelheim (CL): We had already seen considerable